Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Clinical Research Fellow at Dana-Farber Cancer Institute, Visiting Professor at McGill University, shared a post on X about a paper by Carmine Valenza et al. published in Journal of Clinical Oncology:
“High quality RWD to fill a relevant evidence gap: among 501 young (≤40) pts with node-positive, ER+ breast cancer who had received 5y of OFS, extending ET beyond year 5 was associated with better IBCFS and DRFS. Led by super Carmine Valenza!”
Title: Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer: A Cohort Study
Authors: Carmine Valenza, Yue Zheng, Monica Milano, Dario Trapani, Elisa Giordano, Lorenzo Guidi, Pier Paolo Maria Berton Giachetti, Laura Boldrini, Grazia Castellano, Jalissa Katrini, Bianca Malagutti, Gabriele Antonarelli, Fabio Conforti, Eleonora Pagan, Vincenzo Bagnardi, Gregory Kirkner, Claudia Sangalli, Kate Dibble, Marco Colleoni, Meredith Regan, Elisabetta Munzone, Giuseppe Curigliano, Ann Partridge
Read the Full Article in Journal of Clinical Oncology.
More posts featuring Paolo Tarantino.